Cargando…

Role of inflammatory markers in Takayasu arteritis disease monitoring

BACKGROUND: Takayasu arteritis (TA) is an idiopathic large-vessel vasculitis that can result in significant morbidity and mortality secondary to progressive stenosis and occlusion. Monitoring disease progression is crucial to preventing relapse, but is often complicated by the lack of clinical sympt...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Connor, Timothy E, Carpenter, Haley E, Bidari, Sharatchandra, Waters, Michael F, Hedna, Vishnumurthy Shushrutha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4012521/
https://www.ncbi.nlm.nih.gov/pubmed/24678735
http://dx.doi.org/10.1186/1471-2377-14-62
_version_ 1782314943169691648
author O’Connor, Timothy E
Carpenter, Haley E
Bidari, Sharatchandra
Waters, Michael F
Hedna, Vishnumurthy Shushrutha
author_facet O’Connor, Timothy E
Carpenter, Haley E
Bidari, Sharatchandra
Waters, Michael F
Hedna, Vishnumurthy Shushrutha
author_sort O’Connor, Timothy E
collection PubMed
description BACKGROUND: Takayasu arteritis (TA) is an idiopathic large-vessel vasculitis that can result in significant morbidity and mortality secondary to progressive stenosis and occlusion. Monitoring disease progression is crucial to preventing relapse, but is often complicated by the lack of clinical symptoms in the setting of active disease. Although acute phase reactants such as ESR and CRP are generally used as an indicator of inflammation and disease activity, mounting evidence suggests that these markers cannot reliably distinguish active from inactive TA. CASE PRESENTATION: We report a 24-year-old Hispanic female with a 5-year history of TA who presented with stroke-like symptoms and evidence of left MCA occlusion on imaging, despite a history of decreasing inflammatory markers. CTA revealed complete occlusion of the left common carotid artery, left subclavian, and left MCA from their origins. It also revealed a striking compensatory circulation supplying the left anterior circulation as well as the left subclavian as a response to progressive stenosis. CONCLUSION: Monitoring ESR and CRP levels alone may not be a reliable method to evaluate disease progression in patients with TA, and should be taken in context with both patient’s clinical picture and the imaging. We recommend that serial imaging be performed regularly in the setting of active disease to monitor progression and allow for immediate therapy in response to evidence of disease advancement, with a relaxation of the imaging interval once the disease is presumed inactive.
format Online
Article
Text
id pubmed-4012521
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40125212014-05-08 Role of inflammatory markers in Takayasu arteritis disease monitoring O’Connor, Timothy E Carpenter, Haley E Bidari, Sharatchandra Waters, Michael F Hedna, Vishnumurthy Shushrutha BMC Neurol Case Report BACKGROUND: Takayasu arteritis (TA) is an idiopathic large-vessel vasculitis that can result in significant morbidity and mortality secondary to progressive stenosis and occlusion. Monitoring disease progression is crucial to preventing relapse, but is often complicated by the lack of clinical symptoms in the setting of active disease. Although acute phase reactants such as ESR and CRP are generally used as an indicator of inflammation and disease activity, mounting evidence suggests that these markers cannot reliably distinguish active from inactive TA. CASE PRESENTATION: We report a 24-year-old Hispanic female with a 5-year history of TA who presented with stroke-like symptoms and evidence of left MCA occlusion on imaging, despite a history of decreasing inflammatory markers. CTA revealed complete occlusion of the left common carotid artery, left subclavian, and left MCA from their origins. It also revealed a striking compensatory circulation supplying the left anterior circulation as well as the left subclavian as a response to progressive stenosis. CONCLUSION: Monitoring ESR and CRP levels alone may not be a reliable method to evaluate disease progression in patients with TA, and should be taken in context with both patient’s clinical picture and the imaging. We recommend that serial imaging be performed regularly in the setting of active disease to monitor progression and allow for immediate therapy in response to evidence of disease advancement, with a relaxation of the imaging interval once the disease is presumed inactive. BioMed Central 2014-03-28 /pmc/articles/PMC4012521/ /pubmed/24678735 http://dx.doi.org/10.1186/1471-2377-14-62 Text en Copyright © 2014 O¿Connor et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
O’Connor, Timothy E
Carpenter, Haley E
Bidari, Sharatchandra
Waters, Michael F
Hedna, Vishnumurthy Shushrutha
Role of inflammatory markers in Takayasu arteritis disease monitoring
title Role of inflammatory markers in Takayasu arteritis disease monitoring
title_full Role of inflammatory markers in Takayasu arteritis disease monitoring
title_fullStr Role of inflammatory markers in Takayasu arteritis disease monitoring
title_full_unstemmed Role of inflammatory markers in Takayasu arteritis disease monitoring
title_short Role of inflammatory markers in Takayasu arteritis disease monitoring
title_sort role of inflammatory markers in takayasu arteritis disease monitoring
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4012521/
https://www.ncbi.nlm.nih.gov/pubmed/24678735
http://dx.doi.org/10.1186/1471-2377-14-62
work_keys_str_mv AT oconnortimothye roleofinflammatorymarkersintakayasuarteritisdiseasemonitoring
AT carpenterhaleye roleofinflammatorymarkersintakayasuarteritisdiseasemonitoring
AT bidarisharatchandra roleofinflammatorymarkersintakayasuarteritisdiseasemonitoring
AT watersmichaelf roleofinflammatorymarkersintakayasuarteritisdiseasemonitoring
AT hednavishnumurthyshushrutha roleofinflammatorymarkersintakayasuarteritisdiseasemonitoring